MedTech
Diabetes Tech Roundup: Dexcom Acquisition, Stelo AI, Omnipod 5 Update, and iLet Real-World Data
Dexcom buys Nutrisense and updates Stelo app with AI; Insulet lowers Omnipod 5 target to 100 mg/dL; Beta Bionics shares real-world iLet HbA1c data.
